Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
6-Bromocoumarin-3-carboxylic Acid acts on NMDA receptor subtypes Glu1/Glu2. Inhibition of these receptors can be used in therapeutic treatments for various neurological conditions.
您的位置：
